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Background: Chronic kidney disease (CKD) is a multifaceted disease
that contributes to cardiac dysfunction. However, the mechanisms under-
lying the complex relationship between CKD and cardiac impairment re-
mains almost completely unknown. Inflammation is a major player in both
CKD and cardiovascular disease (CVD) and, in this context, nucleotide-
binding oligomerization domain-containing protein 1 (NOD1) is a newly
recognized innate immune receptor involved in both CKD and CVD in-
dependently. NOD1 activation is due to the recruitment of the receptor-
interacting-serine/threonine-protein kinase 2 (RIP2), which induce NOD1
oligomerization and promotes the inflammatory response, being RIP2 a
key partner in the NOD1 activation. Unpublished data from our group has
demonstrated that genetic deletion of NOD1 prevents Ca2+ mishandling
associated to CKD, next step will be to determine whether the absence of
its specific adaptor; RIP2 can also mediate these effects.
Purpose: The main aim of this study was to determine whether NOD1-
RIP2 axis impairs cardiac dysfunction and Ca2+ mishandling prompted by
CKD induced by 5/6 nephrectomy (5/6Nx) in a mice model.
Methods and results: We have analysed intracellular Ca2+ handling in
cardiomyocytes obtained from Wild type (Wt), Nod1−/− and Rip2−/− sham
operated or nephrectomised mice. Compared with Wt-5/6Nx, cardiomy-
ocytes obtained from Nod1−/−5/6Nx and Rip2−/−5/6Nx mice showed a
significant improvement of Ca2+ mishandling, mainly by preventing: i) the
reduction in [Ca2+]i transients amplitude; ii) the rise in their decay time; and
iii) the lower cell contraction. The lack of NOD1 and RIP2 also prevents the
reduced sarcoplasmic reticulum (SR) Ca2+ load and the augmented di-
astolic Ca2+ leak induced by 5/6Nx. Furthermore, the increased diastolic
Ca2+ leak (Ca2+ sparks, spontaneous [Ca2+]i transients and waves) in-
duced by 5/6Nx were also significantly prevented in absence of NOD1 and
RIP2. Genetic deletion of NOD1 or RIP2 did not induces any improvement
of several markers associated with renal dysfunction (urea, phosphate or
fibroblast growth factor-23).
Conclusions: Our results confirmed that the absence of both NOD1 and
RIP2 prevents the intracellular cardiac Ca2+ mishandling in experimental
CKD. NOD1 and RIP2 emerge as novel targets for the development of in-
novative therapeutic strategies for the cardiac remodelling in CKD subjects.
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